Linagliptin and Newer DPP-4 Inhibitors: Newer Uses and Newer Indications

E-ISSN： 2212-3334|5|3|197-202

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.5, Iss.3, 2011-09, pp. : 197-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GLP - 1 Analogs: Newer Molecules, Newer Uses

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 3, Iss. 2, 2009-06 ,pp. : 129-134

Bentham Science Publishers

Access to resources Recommend Favorite

Omalizumab for Asthma: Indications, Off-Label Uses and Future Directions

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 3, 2010-11 ,pp. : 183-192

Bentham Science Publishers

Access to resources Recommend Favorite

Neural Pathways and Neuropeptides Mediate the Therapeutic Actions of DPP IV Inhibitors in Type-2 Diabetes

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 2, 2007-06 ,pp. : 132-135

Bentham Science Publishers

Access to resources Recommend Favorite

CTLA-4Ig: Uses and Future Directions

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 3, Iss. 2, 2009-06 ,pp. : 132-142

Bentham Science Publishers

Access to resources Recommend Favorite

Protection of Traditional Knowledge by Geographical Indications

By Blakeney Michael

International Journal of Intellectual Property Management, Vol. 3, Iss. 4, 2009-07 ,pp. : 357-374

Inderscience Publishers

Access to resources Recommend Favorite